Effects of 12 weeks of atorvastatin therapy on myocardial fibrosis and circulating fibrosis biomarkers in statin-naïve patients with hypertension with atherosclerosis.

about

Effects of 12 weeks of atorvastatin therapy on myocardial fibrosis and circulating fibrosis biomarkers in statin-naïve patients with hypertension with atherosclerosis.

Item

http://www.wikidata.org/entity/Q54373020

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Effects of 12 weeks of atorvas ...... rtension with atherosclerosis.

@en

Effects of 12 weeks of atorvas ...... rtension with atherosclerosis.

@nl

type

Item

label

Effects of 12 weeks of atorvas ...... rtension with atherosclerosis.

@en

Effects of 12 weeks of atorvas ...... rtension with atherosclerosis.

@nl

prefLabel

Effects of 12 weeks of atorvas ...... rtension with atherosclerosis.

@en

Effects of 12 weeks of atorvas ...... rtension with atherosclerosis.

@nl

P1476

Effects of 12 weeks of atorvas ...... ertension with atherosclerosis

@en

P2093

Chi-Sheng Hung

http://www.w3.org/2001/XMLSchema#string

Hsian-Li Kao

http://www.w3.org/2001/XMLSchema#string

Hung-Ju Lin

http://www.w3.org/2001/XMLSchema#string

Jen-Kuang Lee

http://www.w3.org/2001/XMLSchema#string

Yen-Hung Lin

http://www.w3.org/2001/XMLSchema#string

Yen-Ting Lin

http://www.w3.org/2001/XMLSchema#string

Yi-Yao Chang

http://www.w3.org/2001/XMLSchema#string

Yu-Min Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.

Association of longitudinal changes in left ventricular structure and function with myocardial fibrosis: the Multi-Ethnic Study of Atherosclerosis study.

Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials

Comparison the prognostic value of galectin-3 and serum markers of cardiac extracellular matrix turnover in patients with chronic systolic heart failure.

Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans.

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.

The natural history of congestive heart failure: the Framingham study.

The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.

Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis.

P304

1194-1199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JIM-2016-000092

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yen-Wen Wu

P577

2016-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27430242

http://www.w3.org/2001/XMLSchema#string